Table 1:
Survival to Hospital Discharge | Survival to Hospital Discharge with Favorable Neurological Outcome | ||||||
---|---|---|---|---|---|---|---|
Overall (N = 102) | Yes (N = 58) | No (N = 44) | P-value | Yes (N = 53) | No (N = 49) | P-value | |
Intra-arrest DBP | |||||||
DBP above target (25 mmHg for infants, 30 mmHg for children) | 69 (67.6%) | 42 (72.4%) | 27 (61.4%) | 0.2871 | 37 (69.8%) | 32 (65.3%) | 0.6751 |
Post-arrest Hypotension Indicators | |||||||
Any systolic BP < 5th percentile | 39 (38.2%) | 24 (41.4%) | 15 (34.1%) | 0.5391 | 22 (41.5%) | 17 (34.7%) | 0.5431 |
Any diastolic BP < 5th percentile | 8 (7.8%) | 3 (5.2%) | 5 (11.4%) | 0.2861 | 3 (5.7%) | 5 (10.2%) | 0.4761 |
Post-arrest Hypertension Indicators | |||||||
Any systolic BP > 90th percentile | 59 (57.8%) | 34 (58.6%) | 25 (56.8%) | 1.0001 | 32 (60.4%) | 27 (55.1%) | 0.6891 |
Any diastolic BP > 90th percentile | 70 (68.6%) | 46 (79.3%) | 24 (54.5%) | 0.0101 | 41 (77.4%) | 29 (59.2%) | 0.0571 |
Age (Months) | 9.0 [2.5, 43.5] | 8.0 [1.5, 33.5] | 12.0 [3.5, 50.0] | 0.2462 | 7.5 [1.5, 33.5] | 11.5 [3.5, 48.5] | 0.2182 |
Age | 0.2241 | 0.2291 | |||||
< 1 year | 59 (57.8%) | 37 (63.8%) | 22 (50.0%) | 34 (64.2%) | 25 (51.0%) | ||
>= 1 year | 43 (42.2%) | 21 (36.2%) | 22 (50.0%) | 19 (35.8%) | 24 (49.0%) | ||
Male | 59 (57.8%) | 35 (60.3%) | 24 (54.5%) | 0.6861 | 32 (60.4%) | 27 (55.1%) | 0.6891 |
Ethnicity | 0.8211 | 0.9071 | |||||
Hispanic or Latino | 14 (13.7%) | 8 (13.8%) | 6 (13.6%) | 8 (15.1%) | 6 (12.2%) | ||
Not Hispanic or Latino | 72 (70.6%) | 42 (72.4%) | 30 (68.2%) | 37 (69.8%) | 35 (71.4%) | ||
Unknown or Not Reported | 16 (15.7%) | 8 (13.8%) | 8 (18.2%) | 8 (15.1%) | 8 (16.3%) | ||
Race | 0.3991 | 0.3001 | |||||
White | 50 (49.0%) | 27 (46.6%) | 23 (52.3%) | 25 (47.2%) | 25 (51.0%) | ||
Black or African American | 19 (18.6%) | 8 (13.8%) | 11 (25.0%) | 7 (13.2%) | 12 (24.5%) | ||
Other | 7 (6.9%) | 5 (8.6%) | 2 (4.5%) | 5 (9.4%) | 2 (4.1%) | ||
Unknown or Not Reported | 26 (25.5%) | 18 (31.0%) | 8 (18.2%) | 16 (30.2%) | 10 (20.4%) | ||
Pre-existing conditions | |||||||
Respiratory insufficiency | 84 (82.4%) | 46 (79.3%) | 38 (86.4%) | 0.4371 | 43 (81.1%) | 41 (83.7%) | 0.7991 |
Hypotension | 76 (74.5%) | 37 (63.8%) | 39 (88.6%) | 0.0061 | 33 (62.3%) | 43 (87.8%) | 0.0031 |
Congestive heart failure | 11 (10.8%) | 4 (6.9%) | 7 (15.9%) | 0.2001 | 4 (7.5%) | 7 (14.3%) | 0.3461 |
Pneumonia | 12 (11.8%) | 7 (12.1%) | 5 (11.4%) | 1.0001 | 7 (13.2%) | 5 (10.2%) | 0.7621 |
Sepsis | 24 (23.5%) | 14 (24.1%) | 10 (22.7%) | 1.0001 | 13 (24.5%) | 11 (22.4%) | 0.8201 |
Trauma | 6 (5.9%) | 1 (1.7%) | 5 (11.4%) | 0.0821 | 1 (1.9%) | 5 (10.2%) | 0.1021 |
Renal insufficiency | 11 (10.8%) | 6 (10.3%) | 5 (11.4%) | 1.0001 | 5 (9.4%) | 6 (12.2%) | 0.7541 |
Malignancy | 3 (2.9%) | 1 (1.7%) | 2 (4.5%) | 0.5761 | 1 (1.9%) | 2 (4.1%) | 0.6071 |
Congenital heart disease | 65 (63.7%) | 41 (70.7%) | 24 (54.5%) | 0.1021 | 39 (73.6%) | 26 (53.1%) | 0.0401 |
Illness Category | 0.7751 | 0.6601 | |||||
Surgical cardiac | 54 (52.9%) | 33 (56.9%) | 21 (47.7%) | 31 (58.5%) | 23 (46.9%) | ||
Medical cardiac | 13 (12.7%) | 7 (12.1%) | 6 (13.6%) | 7 (13.2%) | 6 (12.2%) | ||
Surgical non-cardiac | 8 (7.8%) | 4 (6.9%) | 4 (9.1%) | 3 (5.7%) | 5 (10.2%) | ||
Medical non-cardiac | 26 (25.5%) | 13 (22.4%) | 13 (29.5%) | 12 (22.6%) | 14 (28.6%) | ||
Unknown | 1 (1.0%) | 1 (1.7%) | 0 (0.0%) | 0 (0.0%) | 1 (2.0%) | ||
Baseline Pediatric Cerebral Performance Category | 0.0983 | 0.0903 | |||||
1 - Normal | 44 (43.1%) | 26 (44.8%) | 18 (40.9%) | 25 (47.2%) | 19 (38.8%) | ||
2 - Mild disability | 32 (31.4%) | 20 (34.5%) | 12 (27.3%) | 17 (32.1%) | 15 (30.6%) | ||
3 - Moderate disability | 16 (15.7%) | 10 (17.2%) | 6 (13.6%) | 9 (17.0%) | 7 (14.3%) | ||
4 - Severe disability | 8 (7.8%) | 2 (3.4%) | 6 (13.6%) | 2 (3.8%) | 6 (12.2%) | ||
5 - Coma/vegetative state | 2 (2.0%) | 0 (0.0%) | 2 (4.5%) | 0 (0.0%) | 2 (4.1%) | ||
Baseline functional status scale | 8.0 [6.0, 11.0] | 8.0 [6.0, 10.0] | 7.5 [6.0, 11.5] | 0.9312 | 8.0 [6.0, 10.0] | 8.0 [6.0, 11.0] | 0.6572 |
Immediate Cause | |||||||
Hypotension | 67 (65.7%) | 35 (60.3%) | 32 (72.7%) | 0.2131 | 33 (62.3%) | 34 (69.4%) | 0.5331 |
Arrhythmia | 16 (15.7%) | 11 (19.0%) | 5 (11.4%) | 0.4121 | 10 (18.9%) | 6 (12.2%) | 0.4221 |
Respiratory decompensation | 46 (45.1%) | 26 (44.8%) | 20 (45.5%) | 1.0001 | 23 (43.4%) | 23 (46.9%) | 0.8421 |
Cyanosis without respiratory decompensation | 1 (1.0%) | 1 (1.7%) | 0 (0.0%) | 1.0001 | 1 (1.9%) | 0 (0.0%) | 1.0001 |
First documented rhythm at time CPR initiated (Collapsed) | 0.1261 | 0.2731 | |||||
Asystole/PEA | 32 (31.4%) | 14 (24.1%) | 18 (40.9%) | 13 (24.5%) | 19 (38.8%) | ||
VF/VT | 7 (6.9%) | 3 (5.2%) | 4 (9.1%) | 3 (5.7%) | 4 (8.2%) | ||
Bradycardia with poor perfusion | 59 (57.8%) | 38 (65.5%) | 21 (47.7%) | 34 (64.2%) | 25 (51.0%) | ||
Unknown | 4 (3.9%) | 3 (5.2%) | 1 (2.3%) | 3 (5.7%) | 1 (2.0%) | ||
Location of CPR Event | 0.1541 | 0.1571 | |||||
PICU | 40 (39.2%) | 19 (32.8%) | 21 (47.7%) | 17 (32.1%) | 23 (46.9%) | ||
CICU | 62 (60.8%) | 39 (67.2%) | 23 (52.3%) | 36 (67.9%) | 26 (53.1%) | ||
Duration of CPR (minutes) | 5.0 [2.0, 11.0] | 4.0 [2.0, 10.0] | 7.0 [3.0, 14.5] | 0.0942 | 4.0 [2.0, 10.0] | 6.0 [3.0, 13.0] | 0.2572 |
Duration of CPR (minutes) | 0.1481 | 0.4361 | |||||
1–5 | 57 (55.9%) | 37 (63.8%) | 20 (45.5%) | 33 (62.3%) | 24 (49.0%) | ||
6–15 | 30 (29.4%) | 16 (27.6%) | 14 (31.8%) | 15 (28.3%) | 15 (30.6%) | ||
16–35 | 12 (11.8%) | 4 (6.9%) | 8 (18.2%) | 4 (7.5%) | 8 (16.3%) | ||
>35 | 3 (2.9%) | 1 (1.7%) | 2 (4.5%) | 1 (1.9%) | 2 (4.1%) | ||
Interventions in place | |||||||
Vascular access | 94 (92.2%) | 53 (91.4%) | 41 (93.2%) | 1.0001 | 48 (90.6%) | 46 (93.9%) | 0.7171 |
Arterial catheter | 101 (99.0%) | 57 (98.3%) | 44 (100.0%) | 1.0001 | 52 (98.1%) | 49 (100.0%) | 1.0001 |
Central venous catheter | 90 (88.2%) | 51 (87.9%) | 39 (88.6%) | 1.0001 | 46 (86.8%) | 44 (89.8%) | 0.7621 |
Vasoactive infusion | 77 (75.5%) | 40 (69.0%) | 37 (84.1%) | 0.1041 | 37 (69.8%) | 40 (81.6%) | 0.1771 |
Invasive mechanical ventilation | 86 (84.3%) | 46 (79.3%) | 40 (90.9%) | 0.1691 | 42 (79.2%) | 44 (89.8%) | 0.1781 |
ETCO2 monitoring | 53 (52.0%) | 31 (53.4%) | 22 (50.0%) | 0.8421 | 30 (56.6%) | 23 (46.9%) | 0.4281 |
Non-invasive ventilation | 11 (10.8%) | 8 (13.8%) | 3 (6.8%) | 0.3431 | 7 (13.2%) | 4 (8.2%) | 0.5291 |
Pharmacologic interventions | |||||||
Epinephrine | 86 (84.3%) | 49 (84.5%) | 37 (84.1%) | 1.0001 | 44 (83.0%) | 42 (85.7%) | 0.7891 |
# of doses (when used) | 2.0 [1.0, 3.0] | 1.0 [1.0, 3.0] | 2.0 [1.0, 4.0] | 0.0612 | 1.0 [1.0, 3.0] | 2.0 [1.0, 4.0] | 0.0422 |
Calcium | 42 (41.2%) | 18 (31.0%) | 24 (54.5%) | 0.0251 | 17 (32.1%) | 25 (51.0%) | 0.0701 |
Sodium bicarbonate | 47 (46.1%) | 24 (41.4%) | 23 (52.3%) | 0.3191 | 22 (41.5%) | 25 (51.0%) | 0.4271 |
Vasopressin | 5 (4.9%) | 3 (5.2%) | 2 (4.5%) | 1.0001 | 2 (3.8%) | 3 (6.1%) | 0.6691 |
Fisher’s exact test.
Wilcoxon rank-sum test.
Cochran-Armitage trend test.